Toggle Main Menu Toggle Search

Open Access padlockePrints

OBIMAP (One-Bead Interchain Multipeptide Assembly Platform)

Lookup NU author(s): Dr Othman AlmusaimiORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

A significant advancement in Merrifield’s classic solid-phase peptide synthesis (SPPS) that greatly expands the scope of accessible peptide structures is reported here. Building upon the one-bead, one-compound (OBOC) concept, this approach enables the simultaneous synthesis of multiple peptides on a single bead, followed by a novel solid-phase interchain assembly reaction to produce the final peptide product. This method, the one-bead interchain multipeptide assembly platform (OBIMAP), successfully generates diverse peptide architectures, including linear, cyclic, and bicyclic structures─ranging from minimal cyclic dipeptides to small proteins─many of which are inaccessible through conventional SPPS. OBIMAP demonstrates superior efficiency in both time and product purity compared to traditional methods. Crucially, it eliminates the need for solution-phase fragment condensation, a common but cumbersome step commonly used in synthesizing therapeutic peptides (30–60 amino acids). In addition to enhancing conventional SPPS methodologies, the OBIMAP enables access to novel classes of peptide architectures, including highly constrained peptides that were previously considered synthetically inaccessible.


Publication metadata

Author(s): Al Musaimi O, Williams DR

Publication type: Article

Publication status: Published

Journal: ACS Bio & Med Chem Au

Year: 2026

Pages: Epub ahead of print

Online publication date: 14/01/2026

Acceptance date: 07/01/2026

Date deposited: 03/02/2026

ISSN (electronic): 2694-2437

Publisher: American Chemical Society

URL: https://doi.org/10.1021/acsbiomedchemau.5c00237

DOI: 10.1021/acsbiomedchemau.5c00237

Data Access Statement: The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsbiomedchemau.5c00237


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Deep Technology Prime – Imperial College London

Share